SCHEMBL6860757

SCHEMBL6860757

CC(=O)C(C)NC(=O)c1cccnc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 1/20 0.57
HDAC6 Q9UBN7 1/20 0.57
LMNA P02545 2/20 0.57
NPC1 O15118 2/20 0.55
RAB9A P51151 2/20 0.55
TP53 P04637 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
PREP P48147 1/20 0.53
FAP Q12884 1/20 0.53
THRB P10828 1/20 0.53
HIF1A Q16665 1/20 0.53
PRKAB2 O43741 1/20 0.52
PRKAG1 P54619 1/20 0.52
PRKAA2 P54646 1/20 0.52
PRKAA1 Q13131 1/20 0.52
PRKAG3 Q9UGI9 1/20 0.52
PRKAG2 Q9UGJ0 1/20 0.52
PRKAB1 Q9Y478 1/20 0.52
ALDH1A1 P00352 2/20 0.51
ROCK2 O75116 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL513251 0.87 LMNA (0.60) HDAC1HDAC6LMNANPC1RAB9A
SCHEMBL2794824 0.87 LMNA (0.60) HDAC1HDAC6LMNANPC1RAB9A
SCHEMBL2797592 0.87 LMNA (0.60) HDAC1HDAC6LMNANPC1RAB9A
SCHEMBL29748479 0.87 LMNA (0.60) HDAC1HDAC6LMNANPC1RAB9A
SCHEMBL30151637 0.87 LMNA (0.60) HDAC1HDAC6LMNANPC1RAB9A
Hydrochloric Acid SCHEMBL8439654 0.86 GPR132 (0.59) HDAC1HDAC6LMNANPC1RAB9A
SCHEMBL8804879 0.86 LMNA (0.56) HDAC1HDAC6LMNANPC1RAB9A
SCHEMBL6574004 0.86 LMNA (0.56) HDAC1HDAC6LMNANPC1RAB9A
SCHEMBL1106964 0.85 HDAC1 (0.62) HDAC1HDAC6LMNANPC1RAB9A
SCHEMBL29589266 0.84 ALDH1A1 (0.57) HDAC1HDAC6LMNANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011089576-A2 NOVEL COMPOSITIONS FOR REDUCING Aß 42 PRODUCTION AND THEIR USE IN TREATING ALZHEIMER'S DISEASE (AD) KAREUS THERAPEUTTICS SA (CH) 2011-07-28 WO disclosed